Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol
Back to Business
Business
September 28, 2026 at 3:45 PM
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
The Hindu Business
Excerpt from The Hindu Business.
